TY - JOUR T1 - Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control JO - Gastroenterología y Hepatología (English Edition) T2 - AU - Vicente Lidón,Raquel AU - García López,Santiago AU - Corsino Roche,Pilar AU - Boudet Barraca,José Miguel AU - Sanz Segura,Patricia AU - García Cámara,Paula AU - Sierra Moros,Eva AU - Gomollón García,Fernando SN - 24443824 M3 - 10.1016/j.gastre.2022.07.001 DO - 10.1016/j.gastre.2022.07.001 UR - https://www.elsevier.es/en-revista-gastroenterologia-hepatologia-english-edition--382-articulo-translation-into-spanish-validation-short-S2444382422001237 AB - ObjectiveMeasurement of patient-perceived outcomes in inflammatory bowel disease (IBD) care is becoming increasingly important. A simple and validated tool exists in English for this purpose, the “IBD-Control”. Our aim is to translate it into Spanish, adapt and validate it. Patients and methodsThe IBD-Control was translated into the Spanish instrument “EII-Control” and prospectively validated. Patients completed the EII-Control and other questionnaires that served as baseline comparators. The gastroenterologist performed a global assessment of the disease, calculated activity indices and recorded treatment. A subgroup of patients repeated the entire assessment at a second visit. The usefulness of IBD-Control summary scales (IBD-Control-8 and IBD-Control-VAS) was also analysed. ResultsA total of 249 IBD patients were included (101 repeated the second visit). Psychometric standards of the test: internal consistency: Cronbach’s α for EII-Control 0.83 with strong correlation between EII-Control-8 and EII-Control-EVA (r = 0.5); reproducibility: intra-class correlation 0.70 for EII-Control; construct validity: moderate to strong correlations between IBD-Control, IBD-Control-8 and IBD-Control-VAS versus comparators; discriminant validity: P < .001; sensitivity to change: same response as quality of life index. Sensitivity and specificity at cut-off point 14 of 0.696 and 0.903, respectively, to determine quiescent status. ConclusionsThe IBD-Control is a valid instrument to measure IBD-Control from the patient’s perspective in our environment and culture. Its simplicity makes it a useful tool to support care. ER -